Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles
Human Vaccines · 2008-01 · 4 (1) · 23-30
DOI: 10.4161/hv.4.1.4806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Vaccines, online erschienen am 27.10.2014. Verfasst von Michelle Finney und 11 weiteren Autor:innen. Beteiligte Einrichtung: Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, UK. michelle.finney@hpa.org.uk. Die Arbeit wurde bisher 25-mal zitiert (Crossref). Gefördert von: Department of Health.
Abstract (Originalsprache)
Serogroup B strains are now responsible for over 80% of meningococcal disease in the UK and no suitable vaccine is available that confers universal protection against all serogroup B strains. Neisseria lactamica shares many antigens with the meningococcus, except capsule and the surface protein PorA. Many of these antigens are thought to be responsible for providing cross-protective immunity to meningococcal disease. We have developed an N. lactamica vaccine using methods developed for meningococcal outer membrane vesicle (OMV) vaccines. The major antigenic components were identified by excision of 11 major protein bands from an SDS-PAGE gel, followed by mass spectrometric identification. These bands contained at least 22 proteins identified from an unassembled N. lactamica genome, 15 of which having orthologues in published pathogenic Neisseria genomes. Western blotting revealed that most of these bands were immunogenic, and antibodies to these proteins generally cross-reacted with N. meningitidis proteins. Sera from mice and rabbits immunized with either N. lactamica or N. meningitidis OMVs produced comparable cross-reactive ELISA titres against OMVs prepared from a panel of diverse meningococcal strains. Mice immunized with either N. meningitidis or N. lactamica OMVs showed no detectable serum bactericidal activity against the panel of target strains except N. meningitidis OMV sera against the homologous strain. Similarly, rabbit antisera to N. lactamica OMVs elicited little or no bactericidal antibodies against the panel of serogroup B meningococcal strains. However, such antisera did mediate opsonophagocytosis, suggestingthat this may did mediate opsonophagocytosis, suggesting that this may be a mechanism by which this vaccine protects in a mouse model of meningococcal bacteraemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Health Protection Agency, Centre for Emergency Preparedness and Response, Porton Down, Salisbury, UK. michelle.finney@hpa.org.uk
Förderung
- Department of Health
Zitieren
APA
Finney, M., Vaughan, T., Taylor, S., Hudson, M. J., Pratt, C., Wheeler, J. X., Vipond, C., Feavers, I., Jones, C., Findlow, J., Borrow, R., & Gorringe, A. (2008). Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Human Vaccines, 4(1), 23-30. https://doi.org/10.4161/hv.4.1.4806
Vancouver
Finney M, Vaughan T, Taylor S, Hudson MJ, Pratt C, Wheeler JX, et al. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Human Vaccines. 2008;4(1):23-30. doi:10.4161/hv.4.1.4806
BibTeX
@article{Finney2008,
author = {Finney, Michelle and Vaughan, Thomas and Taylor, Stephen and Hudson, Michael J and Pratt, Catherine and Wheeler, Jun X and Vipond, Caroline and Feavers, Ian and Jones, Christopher and Findlow, Jamie and Borrow, Ray and Gorringe, Andrew},
title = {Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles},
journal = {Human Vaccines},
year = {2008},
volume = {4},
number = {1},
pages = {23--30},
doi = {10.4161/hv.4.1.4806}
}
EUVIMED